You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

Any previous treatments for active CSC;
Previous prescription of mineralocorticoid receptor antagonists, for cCSC or for other diseases;
Current treatment with corticosteroids (topical or systemic), corticosteroid use within 3 months before possible start of trial treatment, or anticipated start of corticosteroid treatment within the first 2 years from the start of the trial period;
Evidence of another diagnosis that can explain serous SRF or visual loss;
Best-corrected visual acuity < 20/200 (Snellen equivalent);
Profound chorioretinal atrophy in central macular area on ophthalmoscopy and OCT;
Myopia > 6D;
Visual loss and/or serous detachment on OCT < 6 weeks;
Continuous and/or progressive visual loss > 18 months or serous detachment on OCT > 18 months;
No hyperfluorescence on ICGA;
Intraretinal edema on OCT;
(relative) Contraindications for FA or ICGA;
(relative) Contraindications for photodynamic treatment (pregnancy, porphyria, severely disturbed liver function). Pregnancy will not be routinely tested in female patients, but the possibility of pregnancy will be discussed during screening
(relative) Known contraindications for initiation of eplerenone treatment (hyperkalemia, abnormal renal clearance, severe hepatic insufficiency (Child-Pugh C), type 2 diabetes mellitus with microalbuminuria, concomitant use of potassium supplements, potassium-sparing diuretics, strong CYP3A4 inhibitors, or the combination of an ACE-inhibitor and an angiotensin receptor blocking agent). Pregnancy will not be routinely tested in female patients, but the possibility of pregnancy will be discussed during screening;
Soft drusen in treated eye or fellow eye, signs of choroidal neovascularization on ophthalmoscopy and/or FA/ICGA of the study eye.
{"Condition": ["chorioretinal atrophy", "other diseases", "pregnancy", "Soft drusen", "cCSC", "abnormal renal clearance", "visual loss", "Intraretinal edema", "type 2 diabetes mellitus", "hyperkalemia", "serous detachment", "porphyria", "severe hepatic insufficiency", "Visual loss", "microalbuminuria", "disturbed liver function", "contraindications", "CSC", "choroidal neovascularization", "Contraindications"], "Device": [], "Drug": ["corticosteroids", "angiotensin receptor blocking agent", "ACE-inhibitor", "potassium-sparing diuretics", "eplerenone", "potassium supplements", "mineralocorticoid receptor antagonists", "strong CYP3A4 inhibitors"], "Measurement": ["renal clearance", "Child-Pugh", "ICGA", "Best-corrected visual acuity", "Myopia"], "Mood": ["anticipated"], "Multiplier": [], "Negation": ["No"], "Observation": [], "Person": [], "Procedure": ["treatments", "OCT", "ophthalmoscopy", "corticosteroid treatment", "ICGA", "corticosteroid use", "photodynamic treatment", "FA"], "Qualifier": ["study eye", "systemic", "topical", "severely", "Profound", "fellow eye", "treated eye", "progressive", "active", "Continuous", "central macular area"], "ReferencePoint": ["the first 2 years from the start of the trial period", "possible start of trial treatment"], "Scope": ["ophthalmoscopy and OCT", "ACE-inhibitor and an angiotensin receptor blocking agent", "cCSC or for other diseases", "Contraindications for photodynamic treatment", "type 2 diabetes mellitus with microalbuminuria", "Continuous and/or progressive", "potassium supplements, potassium-sparing diuretics, strong CYP3A4 inhibitors, or the combination of an ACE-inhibitor and an angiotensin receptor blocking agent", "ophthalmoscopy and/or FA/ICGA", "FA or ICGA", "pregnancy, porphyria, severely disturbed liver function", "topical or systemic", "Visual loss and/or serous detachment", "treated eye or fellow eye"], "Temporal": ["Previous", "concomitant", "within 3 months before possible start of trial treatment", "Current", "within the first 2 years from the start of the trial period", "\u003c 6 weeks", "\u003e 18 months", "previous"], "Value": ["\u003c 20/200", "hyperfluorescence", "abnormal", "\u003e 6D", "C"], "Visit": []}